Samsara BioCapital’s Aravive, Inc. Common Stock ARAV Stock Holding History

Samsara BioCapital’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-576,066	Closed	-$6.71M	–	41
2020 Q2	$6.71M	Hold	576,066	–	–	2.16%	13
2020 Q1	$3.32M	Hold	576,066	–	–	1.91%	16
2019 Q4	$7.88M	Buy	576,066 +133,333	+30%	+$1.18M	3.77%	9
2019 Q3	$3.32M	Hold	442,733	–	–	2.26%	11
2019 Q2	$2.66M	Hold	442,733	–	–	1.75%	11
2019 Q1	$3.12M	Hold	442,733	–	–	2.45%	11
2018 Q4	$1.56M	Buy	+442,733	New	+$2.55M	1.5%	11

Other funds holding ARAV

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Samsara BioCapital's ARAV Position: Q3 2020 in Review

Samsara BioCapital sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2020, closing a stake of 576,066 shares — an estimated $6.71M sold.

Samsara BioCapital first reported a position in ARAV in Q4 2018 and held it in 7 quarters. The position peaked at $7.88M in Q4 2019. 51 funds tracked by Wall St. Rank hold ARAV as of Q3 2020.

Samsara BioCapital reported no remaining Aravive, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Samsara BioCapital sold 576,066 Aravive, Inc. Common Stock shares in Q3 2020, an estimated $6.71M.
Samsara BioCapital first reported a position in Aravive, Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Samsara BioCapital's Aravive, Inc. Common Stock position peaked at $7.88M in Q4 2019.
51 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2020.

Based on Samsara BioCapital's 13F filing for Q3 2020, filed 16 Nov 2020.